1. Follicular B cell trafficking within the spleen actively restricts humoral immune responses. Hoek KL, Gordy LE, Collins PL, Parekh VV, Aune TM, Joyce S, Thomas JW, Van Kaer L, Sebzda E (2010) Immunity 33(2): 254-65
    › Primary publication · 20691614 (PubMed) · PMC2929658 (PubMed Central)
  2. Expansion of regulatory T cells via IL-2/anti-IL-2 mAb complexes suppresses experimental myasthenia. Liu R, Zhou Q, La Cava A, Campagnolo DI, Van Kaer L, Shi FD (2010) Eur J Immunol 40(6): 1577-89
    › Primary publication · 20352624 (PubMed) · PMC3600978 (PubMed Central)
  3. Evidence for a role of immunoproteasomes in regulating cardiac muscle mass in diabetic mice. Zu L, Bedja D, Fox-Talbot K, Gabrielson KL, Van Kaer L, Becker LC, Cai ZP (2010) J Mol Cell Cardiol 49(1): 5-15
    › Primary publication · 20153750 (PubMed) · PMC2883685 (PubMed Central)
  4. Development of spontaneous anergy in invariant natural killer T cells in a mouse model of dyslipidemia. Braun NA, Mendez-Fernandez YV, Covarrubias R, Porcelli SA, Savage PB, Yagita H, Van Kaer L, Major AS (2010) Arterioscler Thromb Vasc Biol 30(9): 1758-65
    › Primary publication · 20539017 (PubMed) · PMC2963029 (PubMed Central)
  5. Comeback kids: CD8(+) suppressor T cells are back in the game. Van Kaer L (2010) J Clin Invest 120(10): 3432-4
    › Primary publication · 20877006 (PubMed) · PMC2947243 (PubMed Central)
  6. Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. Hao J, Liu R, Piao W, Zhou Q, Vollmer TL, Campagnolo DI, Xiang R, La Cava A, Van Kaer L, Shi FD (2010) J Exp Med 207(9): 1907-21
    › Primary publication · 20696699 (PubMed) · PMC2931174 (PubMed Central)
  7. Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation. Das J, Ren G, Zhang L, Roberts AI, Zhao X, Bothwell AL, Van Kaer L, Shi Y, Das G (2009) J Exp Med 206(11): 2407-16
    › Primary publication · 19808254 (PubMed) · PMC2768861 (PubMed Central)
  8. STAT1 negatively regulates lung basophil IL-4 expression induced by respiratory syncytial virus infection. Moore ML, Newcomb DC, Parekh VV, Van Kaer L, Collins RD, Zhou W, Goleniewska K, Chi MH, Mitchell D, Boyce JA, Durbin JE, Sturkie C, Peebles RS (2009) J Immunol 183(3): 2016-26
    › Primary publication · 19587017 (PubMed) · PMC3755459 (PubMed Central)
  9. Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG. Sadagopal S, Braunstein M, Hager CC, Wei J, Daniel AK, Bochan MR, Crozier I, Smith NE, Gates HO, Barnett L, Van Kaer L, Price JO, Blackwell TS, Kalams SA, Kernodle DS (2009) PLoS One 4(5): e5531
    › Primary publication · 19436730 (PubMed) · PMC2677452 (PubMed Central)
  10. PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells. Parekh VV, Lalani S, Kim S, Halder R, Azuma M, Yagita H, Kumar V, Wu L, Kaer LV (2009) J Immunol 182(5): 2816-26
    › Primary publication · 19234176 (PubMed) · PMC2709814 (PubMed Central)